 |
 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Use of a New Form of the Blood Thinner Heparin Outside the Hospital To Prevent Blood Clots after Hip or Knee Replacement
6 June 2000 | Volume 132 Issue 11 | Page 853
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine.
The summary below is from the full report titled " Ardeparin Sodium for Extended Out-of-Hospital Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement. A Randomized, Double-Blind, Placebo-Controlled Trial." It is in the 6 June 2000 issue of Annals of Internal Medicine (volume 132, pages 853-861). The authors are J.A. Heit, C.G. Elliott, A.A. Trowbridge, B.F. Morrey, M. Gent, and J. Hirsh, for the Ardeparin Arthroplasty Study Group.
What is the problem and what is known about it so far?
Blood clots can form in the deep veins of the leg, a condition called "deep venous thrombosis," as a complication of hip or knee replacement surgery. These clots can break off and travel through the bloodstream to the lungs, shutting off some of the lung's circulation, a condition called "pulmonary embolism." Giving patients blood thinners in the hospital after joint replacement surgery can prevent deep venous thrombosis and pulmonary embolism. However, it remains unknown how long the blood thinners should be continued. Commonly used blood thinners are standard heparin (usually given through an intravenous line), warfarin (given by mouth), or low-molecular-weight heparin (a new form of the drug given by injection under the skin). Low-molecular-weight heparin is more convenient than regular heparin because it can be given once daily and, unlike heparin and warfarin, does not require frequent blood tests to adjust the dose.
Why did the researchers do this particular study?
To find out whether giving joint replacement patients low-molecular-weight heparin for 6 weeks after they go home from the hospital prevents blood clots.
Who was studied?
1195 adults who had total hip or knee replacement surgery and who had completed 4 to 10 days of low-molecular-weight heparin before leaving the hospital.
How was the study done?
Just before patients left the hospital, the researchers randomly assigned them to receive a daily injection of ardeparin sodium (a particular type of low-molecular-weight heparin) or placebo (a substance that looked like the ardeparin but contained no active ingredients). The study patients continued the injections for 6 weeks after they went home. The researchers then followed patients for 12 weeks to see who developed symptoms of thromboembolism or died. Patients who had symptoms of thromboembolism underwent tests to confirm the diagnosis.
What did the researchers find?
Of the 607 patients who got ardeparin, 9 (1.5%) suffered thromboembolism or died compared with 12 of the 588 patients who got placebo (2.0%). Statistical analysis showed that these rates were not significantly different than what one might expect from chance alone.
What were the limitations of the study?
The researchers combined the findings in patients who had knee and hip replacement surgery, so they may have missed a benefit that applied to only one type of surgery. In addition, the study was not large enough to completely rule out a small benefit from ardeparin therapy.
What are the implications of the study?
Without treatment with blood thinner after leaving the hospital, about 2 of every 100 patients will experience thromboembolism or die following joint replacement surgery. Continuing ardeparin for 6 weeks after hospitalization is unlikely to substantially reduce the occurrence of this complication.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  S. B. Haas, R. L. Barrack, G. Westrich, and P. F. Lachiewicz Venous Thromboembolic Disease After Total Hip and Knee Arthroplasty J. Bone Joint Surg. Am., December 1, 2008; 90(12): 2764 - 2780. [Full Text] [PDF]
|
|
|
|
 |
|
 W. H. Geerts, D. Bergqvist, G. F. Pineo, J. A. Heit, C. M. Samama, M. R. Lassen, and C. W. Colwell Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 381S - 453S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Singelyn, C. C.P.M. Verheyen, F. Piovella, H. K. Van Aken, N. Rosencher, and for the EXPERT Study Investigators The Safety and Efficacy of Extended Thromboprophylaxis With Fondaparinux After Major Orthopedic Surgery of the Lower Limb With or Without a Neuraxial or Deep Peripheral Nerve Catheter: The EXPERT Study Anesth. Analg., December 1, 2007; 105(6): 1540 - 1547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Skedgel, R. Goeree, S. Pleasance, K. Thompson, B. O'Brien, and D. Anderson The Cost-Effectiveness of Extended-Duration Antithrombotic Prophylaxis After Total Hip Arthroplasty J. Bone Joint Surg. Am., April 1, 2007; 89(4): 819 - 828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Friedman Optimal Duration of Prophylaxis for Venous Thromboembolism Following Total Hip Arthroplasty and Total Knee Arthroplasty J. Am. Acad. Ortho. Surg., March 1, 2007; 15(3): 148 - 155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Motte, C. M. Samama, J. Guay, J. Barre, J.-Y. Borg, and N. Rosencher Prevention of postoperative venous thromboembolism. Risk assessment and methods of prophylaxis: [La prevention de la thromboembolie veineuse postoperatoire. Evaluation du risque et methodes de prophylaxie] Can J Anesth, June 1, 2006; 53(6_suppl): S68 - S79. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Schiff, S. R. Kahn, I. Shrier, C. Strulovitch, W. Hammouda, E. Cohen, and D. Zukor Identifying Orthopedic Patients at High Risk for Venous Thromboembolism Despite Thromboprophylaxis Chest, November 1, 2005; 128(5): 3364 - 3371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Lieberman and W. K. Hsu Prevention of Venous Thromboembolic Disease After Total Hip and Knee Arthroplasty J. Bone Joint Surg. Am., September 1, 2005; 87(9): 2097 - 2112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. McGuire and P. P. Dobesh Therapeutic Update on the Prevention and Treatment of Venous Thromboembolism Journal of Pharmacy Practice, October 1, 2004; 17(5): 289 - 307. [Abstract] [PDF]
|
|
|
|
|
|
W. H. Geerts, G. F. Pineo, J. A. Heit, D. Bergqvist, M. R. Lassen, C. W. Colwell, and J. G. Ray Prevention of Venous Thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 338S - 400S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mosen, C. G. Elliott, M. J. Egger, M. Mundorff, J. Hopkins, R. Patterson, and R. M. Gardner The Effect of a Computerized Reminder System on the Prevention of Postoperative Venous Thromboembolism Chest, May 1, 2004; 125(5): 1635 - 1641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Kahn and J. S. Ginsberg Relationship Between Deep Venous Thrombosis and the Postthrombotic Syndrome Arch Intern Med, January 12, 2004; 164(1): 17 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Aronow The Prevention of Venous Thromboembolism in Older Adults: Guidelines J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2004; 59(1): M42 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. O'Donnell, L.-A. Linkins, C. Kearon, J. Julian, and J. Hirsh Reduction of Out-of-Hospital Symptomatic Venous Thromboembolism by Extended Thromboprophylaxis With Low-Molecular-Weight Heparin Following Elective Hip Arthroplasty: A Systematic Review Arch Intern Med, June 9, 2003; 163(11): 1362 - 1366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Prandoni, O. Bruchi, P. Sabbion, C. Tanduo, A. Scudeller, C. Sardella, G. Errigo, F. Pietrobelli, G. Maso, and A. Girolami Prolonged Thromboprophylaxis With Oral Anticoagulants After Total Hip Arthroplasty: A Prospective Controlled Randomized Study Arch Intern Med, September 23, 2002; 162(17): 1966 - 1971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Whang and J. R. Lieberman Low-Molecular-Weight Heparin J. Am. Acad. Ortho. Surg., September 1, 2002; 10(5): 299 - 302. [Full Text] [PDF]
|
|
|
|
|
|
J. D. Douketis, J. W. Eikelboom, D. J. Quinlan, A. R. Willan, and M. A. Crowther Short-Duration Prophylaxis Against Venous Thromboembolism After Total Hip or Knee Replacement: A Meta-analysis of Prospective Studies Investigating Symptomatic Outcomes Arch Intern Med, July 8, 2002; 162(13): 1465 - 1471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Hull, G. F. Pineo, P. D. Stein, A. F. Mah, S. M. MacIsaac, O. E. Dahl, M. Butcher, R. F. Brant, W. A. Ghali, D. Bergqvist, et al. Extended Out-of-Hospital Low-Molecular-Weight Heparin Prophylaxis against Deep Venous Thrombosis in Patients after Elective Hip Arthroplasty: A Systematic Review Ann Intern Med, November 20, 2001; 135(10): 858 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kher and M.M. Samama Low-Molecular-Weight Heparins: Weeks or Months Instead of Days of Treatment Clinical and Applied Thrombosis/Hemostasis, October 1, 2001; 7(4): 314 - 320. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Kelly, A. Rudd, R.R. Lewis, and B.J. Hunt Screening for subclinical deep-vein thrombosis QJM, October 1, 2001; 94(10): 511 - 519. [Full Text] [PDF]
|
|
|
|
|
|
W. H. Geerts, J. A. Heit, G. P. Clagett, G. F. Pineo, C. W. Colwell, F. A. Anderson Jr., and H. B. Wheeler Prevention of Venous Thromboembolism Chest, January 1, 2001; 119(1_suppl): 132S - 175S. [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. White, S. Gettner, J. M. Newman, K. B. Trauner, and P. S. Romano Predictors of Rehospitalization for Symptomatic Venous Thromboembolism after Total Hip Arthroplasty N. Engl. J. Med., December 14, 2000; 343(24): 1758 - 1764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Davidson and A. W.A. Lensing Prolonged Prophylaxis after Joint Replacement: Another Step Sideways? Ann Intern Med, June 6, 2000; 132(11): 914 - 915. [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
